Corcept医疗(CORT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CORT Corcept医疗

未开盘 12-29 16:00:00 EST

79.82

-2.83

-3.42%

盘后81.61

+1.79+2.24%

19:57 EST

最高82.98	最低79.67	成交量91.41万
今开82.32	昨收82.65	日振幅4.00%
总市值83.96亿	流通市值69.34亿	总股本1.05亿
成交额7,351万	换手率1.05%	流通股本8,688万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CORT","market":"US","secType":"STK","nameCN":"Corcept医疗","latestPrice":79.82,"timestamp":1767042000000,"preClose":82.65,"halted":0,"volume":914121,"hourTrading":{"tag":"盘后","latestPrice":81.61,"preClose":79.82,"latestTime":"19:57 EST","volume":4974,"amount":398075.2119,"timestamp":1767056279483},"delay":0,"floatShares":86875270,"shares":105188217,"eps":0.873455,"marketStatus":"未开盘","change":-2.83,"latestTime":"12-29 16:00:00 EST","open":82.32,"high":82.98,"low":79.67,"amount":73505996.19207,"amplitude":0.040048,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.873455,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767085200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1081915200000,"exchange":"NASDAQ","adjPreClose":82.65,"preHourTrading":{"tag":"盘前","latestPrice":82.65,"preClose":82.65,"latestTime":"09:14 EST","volume":358,"amount":29612.544948,"timestamp":1767017668398},"postHourTrading":{"tag":"盘后","latestPrice":81.61,"preClose":79.82,"latestTime":"19:57 EST","volume":4974,"amount":398075.2119,"timestamp":1767056279483},"volumeRatio":0.871513,"impliedVol":1.2614,"impliedVolPercentile":0.972},"requestUrl":"/m/hq/s/CORT","defaultTab":"news","newsList":[{"id":"1128768697","title":"Corcept医疗的高皮质醇症销售前景被视为不切实际 -- 市场动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1128768697","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128768697?lang=zh_cn&edition=full","pubTime":"2025-12-17 03:56","pubTimestamp":1765914994,"startTime":"0","endTime":"0","summary":"1454 ET - UBS 分析师在一份报告中表示，Corcept医疗不太可能实现其对高皮质醇症治疗产品的销售预期。针对 Corcept 现有的高皮质醇症产品 Korlym 以及正在等待 FDA 批准的 relacorilant，他们预测至 2030 年高皮质醇症患者的销售额大约为 14 亿美元，远低于公司 30 亿至 50 亿美元的预期。要实现这一目标，Corcept 需扩大其分销能力，并希望医生的行为能够持续改变以及 Korlym 转向 relacorilant 的转化率几乎达到全面，并迅速被接受——分析师表示这一结果不太可能出现。该公司股票下跌 9.5%，报79.01美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","LU1559883803.SGD","CORT","LU0566484027.USD"],"gpt_icon":0},{"id":"2582884656","title":"Corcept医疗2025财年第三财季实现净利润19.36百万美元，同比减少58.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582884656","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582884656?lang=zh_cn&edition=full","pubTime":"2025-11-10 00:01","pubTimestamp":1762704103,"startTime":"0","endTime":"0","summary":"11月10日，Corcept医疗公布财报，公告显示公司2025财年第三财季净利润为19.36百万美元，同比减少58.54%；其中营业收入为2.08亿美元，同比增加13.66%，每股基本收益为0.19美元。从资产负债表来看，Corcept医疗总负债1.92亿美元，其中短期债务1.05百万美元，资产负债比为4.30，流动比率为3.15。机构评级：截至2025年11月10日，当前有4家机构对Corcept医疗目标价做出预测，其中目标均价为135.25美元，其中最低目标价为121.00美元，最高目标价为145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110000238a6ed4ca0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110000238a6ed4ca0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT"],"gpt_icon":0},{"id":"1159752578","title":"Corcept医疗将公布第三季度财务业绩，提供公司动态并举行电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1159752578","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159752578?lang=zh_cn&edition=full","pubTime":"2025-10-29 04:06","pubTimestamp":1761681985,"startTime":"0","endTime":"0","summary":"Corcept医疗将公布第三季度财务业绩，提供公司动态并举行电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0566484027.USD","CORT","LU1559883803.SGD","BK4532"],"gpt_icon":0},{"id":"1176546439","title":"Corcept医疗向欧洲药品管理局提交Relacorilant治疗铂耐药性卵巢癌的上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1176546439","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176546439?lang=zh_cn&edition=full","pubTime":"2025-10-14 20:00","pubTimestamp":1760443228,"startTime":"0","endTime":"0","summary":"Corcept医疗已向欧洲药品管理局递交了Relacorilant的营销授权申请，该药物用于治疗铂耐药性卵巢癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","LU0566484027.USD","LU1559883803.SGD","BK4007","BK4532"],"gpt_icon":0},{"id":"1104984049","title":"FDA受理Corcept Therapeutics关于Relacorilant治疗铂类耐药性卵巢癌患者的新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1104984049","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104984049?lang=zh_cn&edition=full","pubTime":"2025-09-10 20:01","pubTimestamp":1757505691,"startTime":"0","endTime":"0","summary":"FDA受理Corcept Therapeutics关于Relacorilant治疗铂类耐药性卵巢癌患者的新药申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0566484027.USD","LU1559883803.SGD","CORT","BK4007"],"gpt_icon":0},{"id":"2558502691","title":"Corcept医疗2025财年第二财季实现净利润34.61百万美元，同比减少1.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558502691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558502691?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:00","pubTimestamp":1754755229,"startTime":"0","endTime":"0","summary":"8月10日，Corcept医疗公布财报，公告显示公司2025财年第二财季净利润为34.61百万美元，同比减少1.45%；其中营业收入为1.94亿美元，同比增加18.29%，每股基本收益为0.33美元。从资产负债表来看，Corcept医疗总负债1.66亿美元，其中短期债务1.02百万美元，资产负债比为4.84，流动比率为3.06。机构评级：截至2025年8月10日，当前有4家机构对Corcept医疗目标价做出预测，其中目标均价为134.50美元，其中最低目标价为121.00美元，最高目标价为145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000049a6dcb71c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000049a6dcb71c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT"],"gpt_icon":0},{"id":"1186750904","title":"异动解读 | Corcept医疗盘中大跌5.42%，分析师下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1186750904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186750904?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:35","pubTimestamp":1754055339,"startTime":"0","endTime":"0","summary":"Corcept医疗周五盘中大跌5.42%，引发市场关注。这家生物制药公司股价的大幅下跌似乎与多家华尔街分析机构下调其目标价有关。据报道，投资银行Piper Sandler将Corcept医疗的目标价从131美元下调至121美元。分析师目标价的下调通常反映了他们对公司未来业绩预期的变化。尽管具体原因尚不清楚，但可能与公司最新的财务状况、市场竞争格局或行业整体趋势有关。投资者应密切关注公司未来的公告和财报，以获取更多关于公司基本面的信息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CORT"],"gpt_icon":0},{"id":"2556162811","title":"Corcept医疗盘中异动 快速下挫6.01%报63.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556162811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556162811?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:31","pubTimestamp":1754055061,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时31分，Corcept医疗股票出现异动，股价快速下挫6.01%。截至发稿，该股报63.13美元/股，成交量6.4036万股，换手率0.06%，振幅1.80%。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.44%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213102a46fdfed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213102a46fdfed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT","LU1559883803.SGD","LU0566484027.USD","BK4007","BK4532"],"gpt_icon":0},{"id":"2549088558","title":"Corcept医疗盘中异动 早盘股价大跌5.00%报68.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549088558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549088558?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:01","pubTimestamp":1751896868,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时01分，Corcept医疗股票出现波动，股价大幅下挫5.00%。截至发稿，该股报68.66美元/股，成交量12.6917万股，换手率0.12%，振幅3.93%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corcept医疗股票所在的生物技术行业中，整体跌幅为0.69%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707220108979d1e86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707220108979d1e86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1559883803.SGD","BK4532","LU0566484027.USD","BK4007","CORT"],"gpt_icon":0},{"id":"2548886793","title":"Corcept医疗盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886793?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:42","pubTimestamp":1751388124,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时42分，Corcept医疗股票出现波动，股价大幅下跌5.04%。截至发稿，该股报69.70美元/股，成交量46.7432万股，换手率0.44%，振幅5.18%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.92%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702004204a728d150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702004204a728d150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT","LU0566484027.USD","LU1559883803.SGD","BK4007","BK4532"],"gpt_icon":0},{"id":"2517986458","title":"Corcept医疗盘中异动 股价大跌5.05%报56.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517986458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517986458?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:50","pubTimestamp":1741121452,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时50分，Corcept医疗股票出现异动，股价大幅下跌5.05%。截至发稿，该股报56.09美元/股，成交量149.598万股，换手率1.42%，振幅6.96%。Corcept医疗股票所在的生物技术行业中，整体跌幅为0.16%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305045053abe85a69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305045053abe85a69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT","BK4532","LU1559883803.SGD","BK4007","LU0566484027.USD"],"gpt_icon":0},{"id":"2516202548","title":"Corcept医疗2024财年实现净利润1.40亿美元，同比增加33.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516202548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516202548?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931284,"startTime":"0","endTime":"0","summary":"3月3日，Corcept医疗公布财报，公告显示公司2024财年净利润为1.40亿美元，同比增加33.33%；其中营业收入为6.75亿美元，同比增加40.04%，每股基本收益为1.35美元。从资产负债表来看，Corcept医疗总负债1.61亿美元，其中短期债务829000.00美元，资产负债比为5.23，流动比率为3.35。机构评级：截至2025年3月3日，当前有4家机构对Corcept医疗目标价做出预测，其中目标均价为99.75美元，其中最低目标价为76.00美元，最高目标价为130.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000210abe4acf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000210abe4acf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT"],"gpt_icon":0},{"id":"2514538746","title":"Corcept医疗盘中异动 股价大跌5.14%报60.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514538746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514538746?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:27","pubTimestamp":1740673640,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时27分，Corcept医疗股票出现异动，股价快速下跌5.14%。截至发稿，该股报60.11美元/股，成交量64.5305万股，换手率0.61%，振幅6.96%。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.51%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800272098952783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800272098952783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0566484027.USD","BK4532","LU1559883803.SGD","BK4007","CORT"],"gpt_icon":0},{"id":"1165588533","title":"Corcept Therapeutics 2024年第四季度GAAP每股收益$0.26，未达到预期的$0.42，销售额$1.819亿未达到预期的$1.98686亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1165588533","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165588533?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:12","pubTimestamp":1740604374,"startTime":"0","endTime":"0","summary":"公司报告季度销售额为$1.819亿，比分析师一致预期的$1.98686亿低8.45％。以上内容来自Benzinga Earnings专栏，原文如下：Corcept $Therapeutics$  reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.42 by 38.1 percent. This is a 7.14 percent decrease over earnings of $0.28 per share from the same period last year.  The company reported quarterly sales of $181.900 million which missed the analyst consensus estimate of $198.686 million by 8.45 percent.  This is a 34.34 percent increase over sales of $","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Therapeutics 2024年第四季度GAAP每股收益$0.26，未达到预期的$0.42，销售额$1.819亿未达到预期的$1.98686亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2511557410","title":"Corcept医疗盘中异动 股价大涨5.03%报73.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511557410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511557410?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:17","pubTimestamp":1739477868,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时17分，Corcept医疗股票出现异动，股价快速拉升5.03%。截至发稿，该股报73.68美元/股，成交量60.0027万股，换手率0.57%，振幅5.86%。Corcept医疗股票所在的生物技术行业中，整体涨幅为1.14%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214041749a244ef2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214041749a244ef2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LU1559883803.SGD","BK4007","CORT","LU0566484027.USD"],"gpt_icon":0},{"id":"2510807297","title":"HC Wainwright & Co.：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由80.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510807297","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510807297?lang=zh_cn&edition=full","pubTime":"2025-02-11 19:52","pubTimestamp":1739274727,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由80.00美元调整至115.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/11195248088496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CORT"],"gpt_icon":0},{"id":"2508996023","title":"Corcept医疗盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508996023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508996023?lang=zh_cn&edition=full","pubTime":"2025-02-01 02:48","pubTimestamp":1738349318,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日02时48分，Corcept医疗股票出现波动，股价大幅跳水5.01%。截至发稿，该股报66.40美元/股，成交量69.3314万股，换手率0.66%，振幅6.97%。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.75%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201024839961508e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201024839961508e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0566484027.USD","BK4007","LU1559883803.SGD","CORT","BK4532"],"gpt_icon":0},{"id":"2507679771","title":"加拿大投资银行集团：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由78.00美元调整至130.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507679771","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507679771?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:09","pubTimestamp":1738260548,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Corcept Therapeutics(CORT.US)评级，由买入调整至买入评级, 目标价由78.00美元调整至130.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/31020947911041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CORT"],"gpt_icon":0},{"id":"2507802621","title":"Corcept医疗盘中异动 早盘大幅上涨5.25%报64.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507802621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507802621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:33","pubTimestamp":1738247620,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时33分，Corcept医疗股票出现异动，股价急速上涨5.25%。截至发稿，该股报64.76美元/股，成交量6.1377万股，换手率0.06%，振幅3.07%。Corcept医疗股票所在的生物技术行业中，整体涨幅为0.21%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022334096143dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022334096143dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0566484027.USD","BK4532","BK4007","CORT","LU1559883803.SGD"],"gpt_icon":0},{"id":"2505223042","title":"Corcept医疗盘中异动 下午盘快速上涨5.01%报61.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505223042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505223042?lang=zh_cn&edition=full","pubTime":"2025-01-24 02:38","pubTimestamp":1737657509,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日02时38分，Corcept医疗股票出现波动，股价快速上涨5.01%。截至发稿，该股报61.99美元/股，成交量31.4609万股，换手率0.30%，振幅6.10%。Corcept医疗股票所在的生物技术行业中，整体涨幅为1.02%。Corcept医疗公司简介：Corcept Therapeutics Inc是一家商业阶段的制药公司，致力于通过调节激素皮质醇的作用来发现和开发治疗严重代谢、肿瘤和神经精神疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124023830abb62b03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124023830abb62b03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CORT","LU0566484027.USD","BK4007","BK4532","LU1559883803.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corcept.com","stockEarnings":[{"period":"1week","weight":-0.0622},{"period":"1month","weight":0.0053},{"period":"3month","weight":-0.0396},{"period":"6month","weight":0.1189},{"period":"1year","weight":0.5213},{"period":"ytd","weight":0.584}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0065},{"period":"3month","weight":0.0325},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.156},{"period":"ytd","weight":0.1736}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corcept Therapeutics Incorporated于1998年5月13日在特拉华州注册成立。该公司是一家商业阶段公司，从事发现和开发药物，通过调节激素皮质醇的作用来治疗严重的内分泌、肿瘤、代谢和神经系统疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.016463},{"month":2,"riseRate":0.428571,"avgChangeRate":0.014054},{"month":3,"riseRate":0.761905,"avgChangeRate":0.141286},{"month":4,"riseRate":0.52381,"avgChangeRate":-0.001402},{"month":5,"riseRate":0.5,"avgChangeRate":0.00703},{"month":6,"riseRate":0.454545,"avgChangeRate":0.039099},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.006529},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.006283},{"month":9,"riseRate":0.454545,"avgChangeRate":0.062175},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005789},{"month":11,"riseRate":0.5,"avgChangeRate":0.018834},{"month":12,"riseRate":0.454545,"avgChangeRate":0.053222}],"exchange":"NASDAQ","name":"Corcept医疗","nameEN":"Corcept Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corcept医疗(CORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corcept医疗(CORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corcept医疗,CORT,Corcept医疗股票,Corcept医疗股票老虎,Corcept医疗股票老虎国际,Corcept医疗行情,Corcept医疗股票行情,Corcept医疗股价,Corcept医疗股市,Corcept医疗股票价格,Corcept医疗股票交易,Corcept医疗股票购买,Corcept医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corcept医疗(CORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corcept医疗(CORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}